Skip to main content
PMC home page
Parasites & Vectors logoLink to Parasites & Vectors
. 2019 Sep 11;12:447. doi: 10.1186/s13071-019-3703-5

Serum metabolomic alterations in Beagle dogs experimentally infected with Toxocara canis

Wen-Bin Zheng 1,2, Yang Zou 2, Hany M Elsheikha 3, Guo-Hua Liu 1, Min-Hua Hu 4, Shui-Lian Wang 1,✉, Xing-Quan Zhu 1,2,✉
PMCID: PMC6737696  PMID: 31506092

Abstract

Background

Toxocara canis, a globally distributed roundworm, can cause debilitating disease in dogs and humans; however, little is known about the metabolomic response of the hosts to T. canis infection. There is an increasing need to understand the metabolic mechanisms underlying the pathogenesis of T. canis infection in dogs. Here, we examined the metabolomic changes in Beagle dogsʼ serum following T. canis infection using LC-MS/MS.

Results

The metabolic profiles of Beagle dogsʼ serum were determined at 12 h, 24 h, 10 d and 36 d after oral infection with 300 infectious T. canis eggs by LC-MS/MS. We tested whether the T. canis-associated differentially abundant metabolites could distinguish the serum of infected dogs from controls, as measured by the area under the receiver operating characteristic (ROC) curve (AUC). The differentially expressed metabolites were further evaluated by principal components analysis and pathway enrichment analysis. A total of 5756 and 5299 ions were detected in ESI+ and ESI− mode, respectively. ROC curve analysis revealed nine and five metabolite markers, at 12 hpi and 24 hpi to 36 dpi, respectively, with potential diagnostic value for toxocariasis. The levels of taurocholate, estradiol, prostaglandins and leukotriene were significantly changed. Primary bile acid biosynthesis pathway, steroid hormone biosynthesis pathway and biosynthesis of unsaturated fatty acids pathway were significantly altered by T. canis infection.

Conclusions

These findings show that T. canis infection can induce several changes in the dog serum metabolome and that the metabolic signature associated with T. canis infection in dogs has potential for toxocariasis diagnosis.

Keywords: Toxocara canis, Toxocariasis, Beagle dog, Serum, Metabolomic, LC-MS/MS

Background

The canine zoonotic roundworm Toxocara canis is widely distributed all over the world, with a predilection for people in impoverished communities [1, 2]. Toxocara canis is the causative agent of a serious or even a debilitating disease, toxocariasis, whose clinical course is remarkably heterogeneous. Infected individuals can develop ocular larva migrans (OLM), visceral larva migrans (VLM), neurotoxocariasis (NT) or covert toxocariasis (CT) [2]. Toxocariasis is one of the five neglected parasitic infections prioritized by the CDC for public health action [3] (https://www.cdc.gov/parasites/npi/). Without leveraging cutting-edge scientific approaches to counter this parasite, toxocariasis is expected to be amongst the major global parasitic infections by the year 2050 [4].

To complete its complex life-cycle, T. canis employs various pathways to adapt inside the vertebrate host and the eggs have a remarkable ability to withstand adverse environmental conditions, which makes effective control of this parasite a difficult task [5]. Emerging high-throughput ‘omics’ technologies, such as genomics, transcriptomics, proteomics and metabolomics, have been employed to shed light on the pathogenesis of parasitic diseases [6–9]. Additionally, mass spectrometry has been used to characterize somatic proteins and excretory–secretory products of T. canis [10, 11]. Although, a considerable amount of information pertaining to genetic framework of T. canis is available [12], there is a dearth of information on the molecular mechanisms that underpin the pathophysiology of toxocariasis. Furthermore, the metabolic signature specific for T. canis infection in dogs is still unknown.

Metabolomics can be efficiently used to investigate global metabolic profiles since it provides a means to quantify and discriminate metabolites that are associated with a pathophysiological process [13, 14]. In this study, we investigated the differences in the serum metabolic profiles of Beagle dogs with T. canis infection at different stages, compared with healthy uninfected dogs using liquid chromatography–tandem mass spectrometry (LC-MS/MS)-based metabolomics approach. Our data provided another layer of information about the regulatory metabolic constitution that underpins the adaptation of toxocariasis during different stages of infection in the canine host.

Methods

Embryonated eggs

Unembryonated eggs of T. canis were collected from the uteri of fertile T. canis females. The unembryonated eggs were incubated on filter papers with 0.5% formalin solution under 28 °C with 85–95% relative humidity for 28 days. The embryonated eggs were collected from the filter papers and filtered with 200 mesh screens, then stored in 1% formalin solution at 4 °C.

Animals and experimental infection

Fifty-one SPF Beagle dogs aged 6 to 7 weeks-old were purchased from the National Seed Center of Experimental Dogs in accordance with GB 14922.2-2011 “Laboratory animal-microbiological standards and monitoring”. All puppies were raised in the Good Laboratory Practice (GLP) large animal laboratory in the National Seed Center of Experimental Dogs without vaccinating and feeding any medication. These puppies were divided into 4 groups: 12 h group; 24 h group; 10 d group; and 36 d group (Table 1). Puppies from the same litters were split equally between infection group and control group to reduce background differences. Stool examination by the sugar water floating method and routine blood examination using automatic blood analyzer (XT2000 iv; Sysmex, Kobe, Japan) were performed to ensure all puppies were intestinal parasitic infection free. Anti-T. canis IgG antibody was examined by indirect ELISA using larval ES antigen to ensure all puppies were negative of T. canis infection as previously described [15]. Puppies of the infected groups were infected orally with 300 embryonated T. canis eggs, and puppies of the control groups were mock-inoculated with same amount saline after one week of the environmental adaptation in animal laboratory.

Table 1.

Summary of the differential ions at different infection stages

Group Number Ion mode Difference in ion number Upa Upa (MS) Upa (MS2) Downa Downa (MS) Downa (MS2) MS MS2
A12hT vs A12hC (12 hpi) 7 vs 7 ESI(+) 59 31 19 10 28 19 9 38 19
ESI(−) 81 37 22 8 44 23 9 45 17
B24hT vs B24hC (24 hpi) 6 vs 6 ESI(+) 417 330 191 145 87 55 30 246 175
ESI(−) 91 34 17 11 57 19 12 36 23
D10dT vs D10dC (10 dpi) 7 vs 6 ESI(+) 500 137 91 55 363 265 181 356 236
ESI(−) 814 271 150 87 543 358 227 508 314
F36dT vs F36dC (36 dpi) 6 vs 6 ESI(+) 285 138 80 60 147 98 48 178 108
ESI(−) 268 72 30 16 196 88 40 118 56
Open in a new tab

aUp and down indicate upregulated and downregulated differential ion number, respectively

Abbreviations: MS, first mass spectrometry; MS2, secondary mass spectrometry

Preparation of the blood samples

A blood sample from each puppy was collected only once, either at 12 h post-infection (hpi), 24 hpi, 10 days post-infection (dpi) or 36 dpi from the jugular vein, depending on the assigned group. One part of the blood was collected aseptically into tubes with EDTA-K2 for routine blood examination and another part of the blood was collected into tubes without anticoagulant for harvesting serum. The blood was placed at ambient temperature for 1 h, and then the serum was obtained by centrifugation at 10,000×g for 10 min at 4 °C. Serum was divided into 1.5 ml tubes and stored at − 80 °C for non-targeted LC-MS/MS analysis.

Recovery of T. canis and eggs at different infection stages

In order to further confirm the infection of T. canis and minimize the number of animals used, only puppies from the 12 h, 24 h and 36 d groups were humanely killed by KCl under a general anesthetic treatment using Zoletil 50 (Virbac, Nice, France), according to the migration pathways of T. canis. Puppies in the 10 d group were fed albendazole after the experiment, according to veterinary guidance. The liver was shredded to recover larvae by the modified Baermann funnel method for 12 h at 37 °C with 1% mycillin [16]. Fecal eggs of 36 d group dogs were daily examined from 30 to 36 dpi to determine the status of T. canis infection.

Extraction of genomic DNA from T. canis

Genomic DNA was extracted from the embryonated eggs used to infect puppies, and larvae and adults of T. canis recovered from infected puppies using a commercial DNA extraction kit according to the manufacturer’s instructions (TianGen™, Beijing, China). DNA samples were used to amplify the ITS region of T. canis by PCR, as previously described [17]. Positive PCR products were submitted to Sangon Biotech (Shanghai, China) for sequencing. Obtained sequences were aligned with reference sequences available in GenBank using the Basic Local Alignment Search Tool (BLAST).

LC-MS/MS-based metabolomics analysis

Liquid chromatography was performed using the 2777C ultra-performance liquid chromatography (UPLC) system (Waters, Manchester, UK) as previously described [18]. A high-resolution tandem mass spectrometer Xevo G2 XS QTOF (Waters) was used to detect metabolites eluted from the column. The Q-TOF was operated in both positive and negative ion modes. For positive ion mode, the capillary and sampling cone voltages were set at 3.0 kV and 40.0 V, respectively. For negative ion mode, the capillary and sampling cone voltages were set at 2.0 kV and 40.0 V, respectively. The mass spectrometry data were acquired by Centroid MSE mode. The TOF mass range ranged from 50 to 1200 Da and the scan time was 0.2 s. For the MS/MS detection, all precursors were fragmented using 20–40 eV, and the scan time was 0.2 s. During the acquisition, the LE signal was acquired every 3 s to calibrate the mass accuracy. Furthermore, a quality control (QC) sample (pooled aliquots from all analyzed samples) was analyzed every 6 samples and used to evaluate the consistency of the LC-MS during the whole acquisition.

Data analysis

Peak extraction was implemented by commercial software Progenesis QI v.2.2, utilizing raw data (all samples and QC samples), including peak alignment, peak extraction, normalization, deconvolution and compound identification. The data were adjusted by quality control-based robust LOESS signal correction (QC-RLSC) [19]. Then, low-quality ions whose relative standard deviation (RSD) was > 30% compared to QC samples were filtered out. Metabolites were identified based on databases of Human Metabolome Database (HMDB; http://www.hmdb.ca) and Kyoto Encyclopedia of Genes and Genomes (KEGG; http://www.genome.jp/kegg). Principal components analysis (PCA) and partial least squares discriminant analysis (PLS-DA) were performed to discriminate infected puppies and control puppies. In this study, the VIP threshold of the first two principal components of the multivariate PLS-DA model combined with univariate analysis of fold-change (FC) and P-values were used to identify the differentially abundant metabolites, as follows: VIP ≥ 1 and FC ≥ 1.2 or ≤ 0.8333 and P < 0.05. The areas under the receiver operating characteristic (ROC) curves (AUC) of all identified metabolites were analyzed to predict potential biomarkers using MetaboAnalyst v.4.0 [20] (https://www.metaboanalyst.ca). Cluster analysis was performed to reveal the distinct metabolomic signature between infected and control puppies using the heatmap package in R based on the differentially abundant metabolites which were converted to log2 scale. Analysis of metabolic pathways was performed based on the KEGG database to explore the main biochemical pathways involved in T. canis infection. The numbers of eosinophils were analyzed by t-test using GraphPad Prism v.5.

Results

Confirmation of T. canis infection in Beagle dogs

Puppies used in the study were T. canis-free based on the absence of eggs, normal level of blood eosinophils and negative anti-T. canis IgG antibody. Eosinophilia was observed in infected puppies at all infection stages. The results were significantly different between infected and control animals at 10 and 36 dpi (Fig. 1). As expected, there were no significant differences between all four control groups (one-way ANOVA, F(3, 21) = 1.95, P = 0.1519). Anti-T. canis IgG antibodies were detected in animals at 10 and 36 dpi. At 12 hpi, T. canis larvae were found in the livers of 2 puppies; at 24 hpi T. canis larvae were found in the livers of all puppies; at 36 dpi, T. canis were found in the livers of 2 puppies and in the small intestines of all puppies (Additional file 1: Table S1); and no T. canis were found in all control groups. No obvious clinical symptoms were observed in infected puppies, but the infected and control puppies could be still distinguished by the difference in the number of blood eosinophils, the level of anti-T. canis IgG antibody or the metabolic signatures. These differences reached a maximum level at 10 dpi, and then began to decline, indicating that the severity of toxocariasis was correlated with the distribution or growth stage of T. canis. In this study, the embryonated eggs used to infect puppies, and tissue larvae and adults of T. canis recovered from infected puppies were also subjected to PCR, and their sequences had 99% similarity to a published sequences of T. canis from Sichuan Province, China (GenBank: JF837169.1).

Fig. 1.

Fig. 1

Open in a new tab

The number of eosinophils in the infected and control groups at the four indicated infection stages in the blood of Beagle dogs infected with 300 T. canis embryonated eggs were analyzed by t-test using GraphPad Prism v.5. [24 h infection group vs 10 d infection group: t(11) = 6.64, P < 0.001; 10 d infection group vs 10 d control group: t(11) = 7.67, P < 0.001; 10 d infection group vs 36 d infection group: t(11) = 4.22, P < 0.01; 36 d infection group vs 36 d control group: t(10) = 3.37, P < 0.05]. *P < 0.05, **P < 0.01, ***P < 0.001

Serum metabolic profiles

We characterized serum metabolomic changes in T. canis-infected (n = 26) versus uninfected (n = 25) puppies using LC-MS/MS. A total of 8052 and 7843 ions were identified in ESI+ and ESI− mode, respectively. After filtering low-quality ions which had RSD > 30% in QC samples, 5756 and 5299 ions were retained in ESI+ or ESI− mode, respectively. The PCA scores plots of the QC samples, infected groups and control groups are shown in Additional file 2: Figure S1, where QC samples were clustered closely, indicating the good reproducibility of the chromatographic separation of the metabolomic analysis in this study. However, the infected groups and the control groups were not separated by PCA scores plots. PLS-DA analysis showed clear separation between infected and control groups (Fig. 2 and Additional file 3: Figure S2).

Fig. 2.

Fig. 2

Open in a new tab

Partial least squares discriminant analysis (PLS-DA) score scatter plots of ions at 10 dpi in Beagle dogs infected with 300 T. canis embryonated eggs. a PLS-DA score plots of the control group (C) and infection group (T) at 10 dpi in ESI+ mode. b PLS-DA score plots of the control group (C) and infection group (T) at 10 dpi in ESI− mode

Metabolome alterations at different infection stages

As shown in Table 1, the serum metabolomic alterations were clear between infected groups and control groups. The number of upregulated ions was markedly greater than that of downregulated ions at 24 hpi. At 12 hpi, 59 and 81 differential ions were identified in ESI+ and ESI− mode, respectively; at 24 hpi, 417 and 91 differential ions were identified in ESI+ and ESI− mode, respectively; at 10 dpi, 500 and 814 differential ions were identified in ESI+ and ESI− mode, respectively; and at 36 dpi, 285 and 268 differential ions were identified in ESI+ and ESI− mode, respectively. These results are similar to the trend of eosinophils and anti-T. canis IgG antibody, whereby the difference reached a maximum at 10 dpi. All identified ions were clustered according to the expression data at different infection stages in the ESI+ and ESI− mode, respectively (Additional file 4: Figure S3), showing that the control and infection groups can be separated at different infection stages by cluster analysis. The common and unique differential ions at 24 hpi, 10 dpi and 36 dpi are shown by means of Venn diagrams (Fig. 3). Only seven common differential ions were identified in the ESI+, indicating that the host body reacts differently to different stages of T. canis infection.

Fig. 3.

Fig. 3

Open in a new tab

Venn diagrams showing the common and unique differential ions among 24 hpi, 10 dpi and 36 dpi in ESI+ mode (a) and ESI− mode (b)

Identification of potential biomarkers

At 12 hpi, T. canis larvae were detected in the livers of 2 infected animals, but no significant difference was observed in the number of eosinophils or level of anti-T. canis IgG antibody between infected and control groups, and fewer differential ions were identified. Hence, 12 hpi was considered as the initial phase of T. canis infection, and 24 hpi, 10 dpi and 36 dpi were analyzed together as the main clinical course of T. canis infection. The AUC was constructed by MetaboAnalyst v.4.0 to predict the potential biomarkers. Six and three metabolites were found in ESI+ mode and ESI− mode, respectively, with AUC > 0.9, P < 0.05 and FC ≥ 1.2 or ≤ 0.8333 by classical univariate ROC analyses at 12 hpi. Among these, calcitroic acid was considered as an ideal biomarker with an AUC value of 1. There were three metabolites in ESI+ mode and two metabolites in ESI− mode with AUC > 0.8 by classical univariate ROC analyses at 24 hpi to 36 dpi (Table 2). Multivariate ROC curve based exploratory analysis was performed to evaluate the utility of metabolite combination for diagnosing T. canis infection in dogs. The AUC values were 1 (95% CI: 1–1) when using 5 potential biomarkers at 12 hpi, and 0.894 (95% CI: 0.743–1) when using all 5 potential biomarkers at 24 hpi to 36 dpi by multivariate ROC curve analysis (Fig. 4).

Table 2.

Potential biomarker metabolites of Toxocara canis infection in dog serum at 12 hpi and 24 hpi to 36 dpi by LC-MS/MS

Infection stage Ion mode Metabolites Entry AUC P-value Log2(FC) Metabolic pathways
12 hpi ESI(+) O-isovaleryl-l-carnitine C20826 0.959 0.0158 − 0.4179 Not known
12 hpi ESI(+) TG(i-16:0/i-16:0/13:0) HMDB0103789 0.959 0.0056 0.5935 Not known
12 hpi ESI(+) (2E)-3-[4-(sulfooxy)phenyl]prop-2-enoic acid HMDB0125166 0.939 0.0057 − 1.0655 Not known
12 hpi ESI(+) 3’-deoxydihydrostreptomycin C03755 0.939 0.0027 0.3250 Not known
12 hpi ESI(+) Docosahexaenoic acid C06429 0.918 0.0142 − 0.4043 Biosynthesis of unsaturated fatty acids
12 hpi ESI(+) Novapikromyin C20740 0.918 0.0094 0.2805 Not known
12 hpi ESI(−) Calcitroic acid C18230 1.000 0.0487 − 0.4470 Not known
12 hpi ESI(−) Docosapentaenoic acid C16513 0.959 0.0081 − 0.4776 Biosynthesis of unsaturated fatty acids
12 hpi ESI(−) Monoacylglycerol HMDB0011573 0.918 0.0086 − 0.4091 Not known
24 hpi to 36 dpi ESI(+) Biotin amide C01893 0.871 2.21E−05 0.8046 Not known
24 hpi to 36 dpi ESI(+) Iridotrial C06070 0.819 0.0067 0.3800 Biosynthesis of secondary metabolites
24 hpi to 36 dpi ESI(+) {[1-(4-methoxyphenyl)pentan-3-yl]oxy}sulfonic acid HMDB0133010 0.807 0.0010 0.4903 Not known
24 hpi to 36 dpi ESI(−) Angiotensin (5–8) C20972 0.810 0.0008 − 0.3484 Not known
24 hpi to 36 dpi ESI(−) l-Threonate L-Threonate 0.807 0.0025 0.3041 Ascorbate and aldarate metabolism
Open in a new tab

Fig. 4.

Fig. 4

Open in a new tab

Comparisons of differential metabolites based on multivariate ROC curve analysis. a Biomarker metabolites identified at 12 hpi. b Biomarker metabolites identified at 24 hpi, 10 dpi and 36 dpi. Var. (variables) indicates the number of selected features

Metabolic pathways alterations at different infection stages

A total of 1043 and 762 metabolites were identified in the ESI+ and ESI− mode, respectively, according to the KEGG and HMDB annotations. Additionally, a total of 126 and 104 differential metabolic pathways were discovered in ESI+ and ESI− mode, respectively, by the KEGG database. At 12 hpi, 41 and 42 differentially abundant metabolites were identified, which are involved potentially in 32 and 42 differential metabolic pathways in ESI+ and ESI− mode, respectively; at 24 hpi, 75 and 45 differential metabolites were identified, which are involved in 78 and 35 differential metabolic pathways in ESI+ and ESI− mode, respectively; at 10 dpi, 248 and 231 differential metabolites were identified, which are involved in differential 93 and 86 metabolic pathways in ESI+ and ESI− mode, respectively; and at 36 dpi, 109 and 47 differential metabolites were identified, which are involved in 66 and 49 differential metabolic pathways in ESI+ or ESI− mode, respectively (Additional file 5: Table S2). The differential metabolic pathways are illustrated in Fig. 5 by means of Venn diagrams in the ESI+ and ESI− mode at 24 hpi, 10 dpi and 36 dpi. Of the 126 metabolic pathways in ESI+ mode, 30 (23.8%) pathways were involved at 24 hpi, 10 dpi and 36 dpi of T. canis infection, and 51 (40.5%) pathways were involved in two infection stages. Of the 104 metabolic pathways in ESI− mode, 15 (14.4%) pathways were involved at 24 hpi, 10 dpi and 36 dpi of T. canis infection, and 36 (34.6%) pathways were involved in two infection stages. A total of 39 pathways were involved at 24 hpi, 10 dpi and 36 dpi, among which 6 pathways were involved in both ESI+ and ESI− mode. The common differential metabolic pathways at 24 hpi, 10 dpi and 36 dpi with differential metabolites ≥ 2 are listed in Additional file 6: Table S3. Some of these pathways were markedly altered, such as primary bile acid biosynthesis pathway, steroid hormone biosynthesis pathway and arachidonic acid (AA) metabolism pathway (Fig. 6).

Fig. 5.

Fig. 5

Open in a new tab

Venn diagram showing the common and unique differential metabolic pathways among 24 hpi, 10 dpi and 36 dpi in ESI+ mode (a) and ESI− mode (b)

Fig. 6.

Fig. 6

Open in a new tab

Schematic overview of the differential metabolites involved in arachidonic acid metabolites pathway at 12 hpi, 10 dpi and 36 dpi. Red and blue arrows represent upregulation and downregulation, respectively. No arrows indicate that the metabolites were not significantly different in this infection stage

Discussion

In this study, a non-targeted LC-MS/MS-based serum metabolomic investigation was performed to identify T. canis-specific changes in metabolites and metabolic pathways, and to discover potential biomarkers of T. canis infection in Beagle dogs. Nine potential biomarkers were identified at 12 hpi (e.g. traumatic acid and docosapentaenoic acid) by ROC analysis, suggesting good predictive value. These compounds are mainly involved in the biosynthesis and metabolism of fatty acids. At 12 hpi to 36 dpi, five potential biomarkers were detected (e.g. iridotrial and L-threonate), which are involved in the biosynthesis of secondary metabolites, and ascorbate and aldarate metabolism. These metabolites were evaluated by multivariate ROC analysis, indicating that metabolites combination can have good diagnostic potential for detection of T. canis infection in dogs.

Many different metabolites were identified at 24 hpi, 10 dpi and 36 dpi; however, only seven shared differential metabolites were identified between 24 hpi, 10 dpi and 36 dpi (Fig. 3), indicating that the host body reacts differently to different stages of T. canis infection. Additionally, 39 potential differential metabolic pathways were identified at 24 hpi, 10 dpi and 36 dpi in dogs, indicating that some important metabolic pathways were involved in the full spectrum of T. canis infection in dogs.

At approximately 24 hpi, the majority of T. canis larvae reach the liver, the organ that plays an important role in the synthesis and secretion of bile. The primary bile acid biosynthesis pathway and bile secretion pathway were altered in dogs after T. canis infection. The level of cholic acid, one of the primary bile acids, was upregulated 3.28 times; many of its intermediate metabolites were also upregulated. At 10 dpi, the level of cholic acid in infected puppies was lower than that in the control group with a downregulation in the intermediate metabolites in the primary bile acid biosynthesis pathway. However, the level of taurocholate was upregulated 7.55 times and taurochenodeoxycholate was upregulated abnormally 13.82 times; both of these metabolites have anti-inflammatory activities [21, 22]. At 36 dpi, the level of chenodeoxycholate, one of the primary bile acids, was reduced to half of the normal level, as well as cholic acid. The increase of primary bile acids can increase the secretion of bile which is discharged directly into the duodenum by the liver or gall-bladder; the duodenum is also the main place where T. canis penetrates the intestinal wall during the first stage of infection. Therefore, a dysregulated primary bile acid biosynthesis pathway may contribute to T. canis migration from the duodenum to the liver during early infection. At 10 dpi, T. canis develops into the fourth-stage larvae after molting in the small intestine of the puppy. Whether the upregulation of taurocholate and taurochenodeoxycholate eliminates inflammation and inhibits T. canis, or provides a better condition for T. canis larval migration and development, remains to be further studied.

The steroid hormone biosynthesis pathway was significantly downregulated during the entire duration of T. canis infection in puppies. At 24 hpi, the level of estradiol was downregulated 0.73 times. At 10 dpi, the most significant change was the downregulation of progesterone to 0.51 times and one of its metabolites, 3α,20α,21-trihydroxy-5β-pregnan-11-one, was downregulated 0.16 times. The level of testosterone metabolites, such as dihydroandrosterone was downregulated 0.26 times. Additionally, estradiol was downregulated 0.31 times, less than that at 24 hpi. The steroid hormone biosynthesis pathway gradually restored its normal level at 36 dpi. A previous study showed that estradiol can promote T. gondii infection in vitro and in vivo [23]. Furthermore, it has been shown that progesterone treatment increases the parasite load of Taenia crassiceps in mice [24]. Sex hormones are known to affect the parasite infection course, leading to resistance or susceptibility through modulating Th1/Th2 response [25]. Therefore, it is reasonable to assume that the host immune defense system was activated via the downregulation of steroid hormone biosynthesis pathway during T. canis infection in puppies, and more intermediate metabolites in steroid hormone biosynthesis pathway may play an important role in the interaction between T. canis and hosts, such as estradiol and 3α,20α,21-Trihydroxy-5β-pregnan-11-one. The detailed connection between T. canis and other metabolites of the steroid hormone biosynthesis pathway requires further investigation.

Another notable finding was the downregulation of the biosynthesis of the unsaturated fatty acids pathway. The level of linoleic acid was downregulated 0.56 times at 24 hpi. At 10 dpi, levels of various unsaturated fatty acids, such as linoleic acid, adrenic acid, eicosapentaenoic acid and 11,14,17-eicosatrienoic acid, were downregulated to about half of the normal levels. The level of eicosapentaenoic acid was downregulated 0.83 times at 36 dpi. These results indicate that unsaturated fatty acids, which maintain the relative fluidity of cell membrane and synthesize prostaglandins (PGs), could play an important role in the T. canis-host interaction. Furthermore, linoleic acid metabolism pathway, α-linolenic acid metabolism pathway and AA metabolism pathway were downregulated throughout the infection stages of T. canis in puppies, while it is notable that the levels of 11-dehydro-thromboxane B2 (TXB2)/PGG2/2, 3-dinor-8-iso PGF1α (which are isomers and can’t be distinguished by LC-MS/MS) were upregulated 1.5044 times and 2, 3-dinor-8-iso PGF2α was upregulated 1.59 times at 24 hpi in the AA metabolism pathway (Fig. 6). However, the level of other differential metabolites involved in the AA metabolism pathway were downregulated to about half of the normal level at 24 hpi and 10 dpi. Due to the presence of many isomers in the AA metabolism pathway, it was not possible to precisely identify each differential metabolite.

Nevertheless, the present study confirmed that the levels of multiple hydroperoxyeicosatetraenoic acid (HPETEs), PGs and leukotriene were downregulated at 24 hpi and 10 dpi. The level of leukotriene A4 (LTA4) was upregulated 1.57 times at 36 dpi. Because nematodes cannot synthesize AA [26], they must utilize the host’s AA to synthesize and release AA metabolites which are important to their survival and virulence. A previous study showed that the level of leukotriene was upregulated in T. canis infection at 3, 6, 18 and 24 dpi in Wistar rats [27]. Nematode-derived signals can directly induce leukotriene production by eosinophils and that leukotriene signaling is a major contributor to nematode-induced eosinophil accumulation in the lungs [28]. However, in our study, the level of leukotriene was downregulated at 24 hpi and 10 dpi in dogs, although, the number of eosinophils was increased at the two infection stages. Therefore, we speculate that the upregulation of TXB2/PGG2/2, 3-dinor-8-iso PGF1α/2α in the dogs’ serum was derived from T. canis, which may ensure larval migration at the initial infection stage. Subsequently, the levels of AA metabolites began to decline in the dog serum, possibly due to the slowdown of inflammatory responses of the host through downregulation of the AA metabolites pathways. This may also explain why overt clinical signs are rarely observed in dogs infected with T. canis.

Conclusions

In this study, the metabolome alterations of dogs’ serum as a result of T. canis infection were identified, providing new insights into the mechanisms underpinning the pathophysiology of this infection. Serum metabolomic profiles were different between uninfected and infected dogs at different infection stages. Our non-targeted metabolomics study enabled the identification of defined infection stage-specific differences in metabolites and pathways involved in lipid, carbohydrate and steroid hormone metabolism. Further studies are needed to characterize the mechanisms that underpin these alterations and their potential involvement in the pathogenesis of toxocariasis, especially at the early stages of T. canis infection.

Supplementary information

13071_2019_3703_MOESM1_ESM.docx (14.8KB, docx)

Additional file 1: Table S1. The recovery of Toxocara canis larvae from the liver and small intestine of puppies at 3 stages post-infection with 300 T. canis eggs.

13071_2019_3703_MOESM2_ESM.tif (7.5MB, tif)

Additional file 2: Figure S1. Principal components analysis (PCA) score scatter plots of metabolites, including control group (C), infection group (T) and quality control (QC) samples, in ESI+ (a) and ESI− (b) mode.

13071_2019_3703_MOESM3_ESM.tif (15MB, tif)

Additional file 3: Figure S2. Partial least squares discriminant analysis (PLS-DA) score scatter plots of ions at 12 hpi, 24 hpi and 36 dpi in Beagle dogs infected with 300 T. canis embryonated eggs. a–c PLS-DA score plots of the control group (C) and infection group (T) at 12 hpi, 24 hpi and 36 dpi in ESI+ mode. d–f PLS-DA score plots of the control group (C) and infection group (T) at 12 hpi, 24 hpi and 36 dpi in ESI− mode.

13071_2019_3703_MOESM4_ESM.tif (12.5MB, tif)

Additional file 4: Figure S3. Heatmaps based on hierarchical clustering of the differentially abundant ions. a–d Heatmaps of the control group (C) and infection group (T) at 12 hpi, 24 hpi, 10 dpi and 36 dpi in ESI+ mode. e-h Heatmaps of the control group (C) and infection group (T) at 12 hpi, 24 hpi, 10 dpi and 36 dpi in ESI− mode.

13071_2019_3703_MOESM5_ESM.xlsx (69.6KB, xlsx)

Additional file 5: Table S2. Differential pathways of differential metabolites in ESI+ and ESI− mode at different infection stages by KEGG enrichment analysis.

13071_2019_3703_MOESM6_ESM.docx (18KB, docx)

Additional file 6: Table S3. The common differential metabolic pathways with differential metabolites ≥ 2 in ESI+ or ESI− mode during Toxocara canis infection in Beagle dogs at 24 hpi, 10 dpi and 36 dpi.

Acknowledgments

We thank BGI-Shenzhen for technical assistance with the LC–MS/MS analysis.

Abbreviations

LC-MS/MS

liquid chromatography–tandem mass spectrometry

ES

excretory–secretory

ROC

receiver operating characteristic

AUC

area under curve

PCA

principal components analysis

PLS-DA

partial least squares discriminant analysis

AA

arachidonic acid

PG

prostaglandins

Authors’ contributions

XQZ, HME and SLW conceived and designed the study, and critically revised the manuscript. WBZ and YZ performed the experiment, analyzed the proteomic data and drafted the manuscript with the help of HME. GHL and MHH participated in the implementation of the study. All authors read and approved the final manuscript.

Funding

Project support was provided by the Elite Program of Chinese Academy of Agricultural Sciences and the Agricultural Science and Technology Innovation Programme (ASTIP) (Grant No. CAAS-ASTIP-2016-LVRI-03).

Availability of data and materials

All relevant data are within the paper and its additional files. The metabolomic data are available in the MetaboLights database under Accession No. MTBLS971 (http://www.ebi.ac.uk/metabolights/MTBLS971).

Ethics approval and consent to participate

This study was approved by the Animal Administration and Ethics Committee of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (Permit No: 2018-015). The Beagle dogs used in this study were handled in accordance with good animal practices required by the Animal Ethics Procedures and Guidelines of the Peopleʼs Republic of China.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Wen-Bin Zheng, Email: wenbinzheng1@126.com.

Yang Zou, Email: zouyangdr@163.com.

Hany M. Elsheikha, Email: Hany.Elsheikha@nottingham.ac.uk

Guo-Hua Liu, Email: liuguohua5202008@163.com.

Min-Hua Hu, Email: 85539817@qq.com.

Shui-Lian Wang, Email: wangshuilian1234@126.com.

Xing-Quan Zhu, Email: xingquanzhu1@hotmail.com.

Supplementary information

Supplementary information accompanies this paper at 10.1186/s13071-019-3703-5.

References

  • 1.Ma G, Holland CV, Wang T, Hofmann A, Fan CK, Maizels RM, et al. Human toxocariasis. Lancet Infect Dis. 2018;18:e14–e24. doi: 10.1016/S1473-3099(17)30331-6. [DOI] [PubMed] [Google Scholar]
  • 2.Chen J, Liu Q, Liu GH, Zheng WB, Hong SJ, Sugiyama H, et al. Toxocariasis: a silent threat with a progressive public health impact. Infect Dis Poverty. 2018;7:59. doi: 10.1186/s40249-018-0437-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Hotez Peter J., Wilkins Patricia P. Toxocariasis: America's Most Common Neglected Infection of Poverty and a Helminthiasis of Global Importance? PLoS Neglected Tropical Diseases. 2009;3(3):e400. doi: 10.1371/journal.pntd.0000400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Hotez PJ. Human parasitology and parasitic diseases: heading towards 2050. Adv Parasitol. 2018;100:29–38. doi: 10.1016/bs.apar.2018.03.002. [DOI] [PubMed] [Google Scholar]
  • 5.Schnieder T, Laabs EM, Welz C. Larval development of Toxocara canis in dogs. Vet Parasitol. 2011;175:193–206. doi: 10.1016/j.vetpar.2010.10.027. [DOI] [PubMed] [Google Scholar]
  • 6.Jex AR, Liu S, Li B, Young ND, Hall RS, Li Y, et al. Ascaris suum draft genome. Nature. 2011;479:529–533. doi: 10.1038/nature10553. [DOI] [PubMed] [Google Scholar]
  • 7.Lee Hyun Jae, Georgiadou Athina, Walther Michael, Nwakanma Davis, Stewart Lindsay B., Levin Michael, Otto Thomas D., Conway David J., Coin Lachlan J., Cunnington Aubrey J. Integrated pathogen load and dual transcriptome analysis of systemic host-pathogen interactions in severe malaria. Science Translational Medicine. 2018;10(447):eaar3619. doi: 10.1126/scitranslmed.aar3619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Negrao F, Eberlin MN, Giorgio S. Proteomic approaches for drug discovery against tegumentary leishmaniasis. Biomed Pharmacother. 2017;95:577–582. doi: 10.1016/j.biopha.2017.08.089. [DOI] [PubMed] [Google Scholar]
  • 9.Chen XQ, Zhou CX, Elsheikha HM, He S, Hu GX, Zhu XQ. Profiling of the perturbed metabolomic state of mouse spleen during acute and chronic toxoplasmosis. Parasit Vectors. 2017;10:339. doi: 10.1186/s13071-017-2282-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Sperotto Rita Leal, Kremer Frederico Schmitt, Aires Berne Maria Elisabeth, Costa de Avila Luciana F., da Silva Pinto Luciano, Monteiro Karina Mariante, Caumo Karin Silva, Ferreira Henrique Bunselmeyer, Berne Natália, Borsuk Sibele. Proteomic analysis of Toxocara canis excretory and secretory (TES) proteins. Molecular and Biochemical Parasitology. 2017;211:39–47. doi: 10.1016/j.molbiopara.2016.09.002. [DOI] [PubMed] [Google Scholar]
  • 11.da Silva MB, Urrego AJ, Oviedo Y, Cooper PJ, Pacheco LGC, Pinheiro CS, et al. The somatic proteins of Toxocara canis larvae and excretory–secretory products revealed by proteomics. Vet Parasitol. 2018;259:25–34. doi: 10.1016/j.vetpar.2018.06.015. [DOI] [PubMed] [Google Scholar]
  • 12.Zhu XQ, Korhonen PK, Cai H, Young ND, Nejsum P, von Samson-Himmelstjerna G, et al. Genetic blueprint of the zoonotic pathogen Toxocara canis. Nat Commun. 2015;6:6145. doi: 10.1038/ncomms7145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Nicholson JK, Wilson ID, Lindon JC. Pharmacometabonomics as an effector for personalized medicine. Pharmacogenomics. 2011;12:103–111. doi: 10.2217/pgs.10.157. [DOI] [PubMed] [Google Scholar]
  • 14.Nicholson JK, Lindon JC, Holmes E. ‛Metabonomicsʼ: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. 1999;29:1181–1189. doi: 10.1080/004982599238047. [DOI] [PubMed] [Google Scholar]
  • 15.Regis SC, Mendonca LR, Silva Ndos S, Dattoli VC, Alcantara-Neves NM, Barrouin-Melo SM. Seroprevalence and risk factors for canine toxocariasis by detection of specific IgG as a marker of infection in dogs from Salvador, Brazil. Acta Trop. 2011;120:46–51. doi: 10.1016/j.actatropica.2011.05.011. [DOI] [PubMed] [Google Scholar]
  • 16.Pahari TK, Sasmal NK. Infection of Japanese quail with Toxocara canis larvae and establishment of patent infection in pups. Vet Parasitol. 1990;35:357–364. doi: 10.1016/0304-4017(90)90140-7. [DOI] [PubMed] [Google Scholar]
  • 17.Mikaeili F, Mathis A, Deplazes P, Mirhendi H, Barazesh A, Ebrahimi S, et al. Differentiation of Toxocara canis and Toxocara cati based on PCR-RFLP analyses of rDNA-ITS and mitochondrial cox1 and nad1 regions. Acta Parasitol. 2017;62:549–556. doi: 10.1515/ap-2017-0066. [DOI] [PubMed] [Google Scholar]
  • 18.Chen XQ, Elsheikha HM, Hu RS, Hu GX, Guo SL, Zhou CX, et al. Hepatic metabolomics investigation in acute and chronic murine toxoplasmosis. Front Cell Infect Microbiol. 2018;8:189. doi: 10.3389/fcimb.2018.00189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011;6:1060–1083. doi: 10.1038/nprot.2011.335. [DOI] [PubMed] [Google Scholar]
  • 20.Xia J, Sinelnikov I, Han B, Wishart DS. MetaboAnalyst 30- making metabolomics more meaningful. Nucleic Acids Res. 2015;43:W251–W257. doi: 10.1093/nar/gkv380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wang X, Zhang Z, He X, Mao W, Zhou L, Li P. Taurochenodeoxycholic acid induces NR8383 cells apoptosis via PKC/JNK-dependent pathway. Eur J Pharmacol. 2016;786:109–115. doi: 10.1016/j.ejphar.2016.06.007. [DOI] [PubMed] [Google Scholar]
  • 22.Lempp FA, Wiedtke E, Qu B, Roques P, Chemin I, Vondran FWR, et al. Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes. Hepatology. 2017;66:703–716. doi: 10.1002/hep.29112. [DOI] [PubMed] [Google Scholar]
  • 23.Zhang X, Liu J, Li M, Fu Y, Zhang T, Han Q, et al. Role of an estradiol regulatory factor-hydroxysteroid dehydrogenase (HSD) in Toxoplasma gondii infection and pathogenicity. J Steroid Biochem Mol Biol. 2017;174:176–182. doi: 10.1016/j.jsbmb.2017.09.001. [DOI] [PubMed] [Google Scholar]
  • 24.Vargas-Villavicencio JA, Larralde C, De Leon-Nava MA, Morales-Montor J. Regulation of the immune response to cestode infection by progesterone is due to its metabolism to estradiol. Microbes Infect. 2005;7:485–493. doi: 10.1016/j.micinf.2004.12.015. [DOI] [PubMed] [Google Scholar]
  • 25.Escobedo G, Lopez-Griego L, Morales-Montor J. Neuroimmunoendocrine modulation in the host by helminth parasites: a novel form of host-parasite coevolution? Neuroimmunomodulation. 2009;16:78–87. doi: 10.1159/000180262. [DOI] [PubMed] [Google Scholar]
  • 26.Liu LX, Weller PF. Arachidonic acid metabolism in filarial parasites. Exp Parasitol. 1990;71:496–501. doi: 10.1016/0014-4894(90)90076-O. [DOI] [PubMed] [Google Scholar]
  • 27.Carlos D, Machado ER, De Paula L, Sa-Nunes A, Sorgi CA, Jamur MC, et al. Evidence for eosinophil recruitment, leukotriene B4 production and mast cell hyperplasia following Toxocara canis infection in rats. Braz J Med Biol Res. 2011;44:319–326. doi: 10.1590/S0100-879X2011000400008. [DOI] [PubMed] [Google Scholar]
  • 28.Patnode ML, Bando JK, Krummel MF, Locksley RM, Rosen SD. Leukotriene B4 amplifies eosinophil accumulation in response to nematodes. J Exp Med. 2014;211:1281–1288. doi: 10.1084/jem.20132336. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

13071_2019_3703_MOESM1_ESM.docx (14.8KB, docx)

Additional file 1: Table S1. The recovery of Toxocara canis larvae from the liver and small intestine of puppies at 3 stages post-infection with 300 T. canis eggs.

13071_2019_3703_MOESM2_ESM.tif (7.5MB, tif)

Additional file 2: Figure S1. Principal components analysis (PCA) score scatter plots of metabolites, including control group (C), infection group (T) and quality control (QC) samples, in ESI+ (a) and ESI− (b) mode.

13071_2019_3703_MOESM3_ESM.tif (15MB, tif)

Additional file 3: Figure S2. Partial least squares discriminant analysis (PLS-DA) score scatter plots of ions at 12 hpi, 24 hpi and 36 dpi in Beagle dogs infected with 300 T. canis embryonated eggs. a–c PLS-DA score plots of the control group (C) and infection group (T) at 12 hpi, 24 hpi and 36 dpi in ESI+ mode. d–f PLS-DA score plots of the control group (C) and infection group (T) at 12 hpi, 24 hpi and 36 dpi in ESI− mode.

13071_2019_3703_MOESM4_ESM.tif (12.5MB, tif)

Additional file 4: Figure S3. Heatmaps based on hierarchical clustering of the differentially abundant ions. a–d Heatmaps of the control group (C) and infection group (T) at 12 hpi, 24 hpi, 10 dpi and 36 dpi in ESI+ mode. e-h Heatmaps of the control group (C) and infection group (T) at 12 hpi, 24 hpi, 10 dpi and 36 dpi in ESI− mode.

13071_2019_3703_MOESM5_ESM.xlsx (69.6KB, xlsx)

Additional file 5: Table S2. Differential pathways of differential metabolites in ESI+ and ESI− mode at different infection stages by KEGG enrichment analysis.

13071_2019_3703_MOESM6_ESM.docx (18KB, docx)

Additional file 6: Table S3. The common differential metabolic pathways with differential metabolites ≥ 2 in ESI+ or ESI− mode during Toxocara canis infection in Beagle dogs at 24 hpi, 10 dpi and 36 dpi.

Data Availability Statement

All relevant data are within the paper and its additional files. The metabolomic data are available in the MetaboLights database under Accession No. MTBLS971 (http://www.ebi.ac.uk/metabolights/MTBLS971).

Articles from Parasites & Vectors are provided here courtesy of BMC

RESOURCES